3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Colorectal Neoplasms
8
Polycythemia Vera
6
Multiple Myeloma
5
Prostatic Neoplasms
4
Neoplasms
4
Colonic Neoplasms
4
Cardiovascular Diseases
4
Venous Thromboembolism
3
Thrombocythemia, Essential
3
Precancerous Conditions
3
Ovarian Neoplasms
3
Neoplasms, Plasma Cell
3
Myeloproliferative Disorders
3
Melanoma
3
Esophageal Neoplasms
3
Barrett Esophagus
3
Tobacco Use Disorder
2
Thrombosis
2
Thromboembolism
2
Stomach Neoplasms
2
Rectal Neoplasms
2
Head and Neck Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Breast Neoplasms
2
Adenomatous Polyps
2
Vascular Diseases
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Triple Negative Breast Neoplasms
1
Stroke
1
Interventions
Tissue Array Analysis
1
Standard of Care
1
Risk Factors
1
Radiotherapy
1
Magnetic Resonance Spectroscopy
1
Injections
1
Ferrosoferric Oxide
1
Clopidogrel
1
Aspirin
1
Anticoagulants
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Ischemic Stroke
×
Aspirin
×
Clear all
NCT05507645
2024-09-05
PUMICE
Beijing Tiantan Hospital
Phase 3
Completed
1,446 enrolled